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The cellular membrane has many different functions, including controlled 
transport of substances in and out of the cell. By studying different lipid components of 
the membrane, scientists can examine each lipids role in membrane structure and 
transport. Due to the complexity of working with cells in vivo, scientists are frequently 
challenged with uncovering fundamental roles of specific lipids in membrane function. 
For this reason, there is a collaborative interest within the scientific community in 
constructing artificial cells that mimic the behaviors of cell membranes. Giant unilamellar 
vesicles (GUVs) are a type of artificial cell that allow for intrinsic study of membrane 
composition and related properties. 
The focus of our studies is to systematically evaluate the conditions under which 
GUVs can be synthesized and to establish a reliable protocol which generates a relatively 
uniform sized vesicle in a time efficient manner with moderately low-cost materials and 
instrumentation. In this study, lipid composition, type of phospholipid polar head group, 
length of esterified fatty acid chain, and degree of fatty acid unsaturation are varied along 
with exploring other synthesis conditions to optimize GUV formation. Synthesis of the 
vesicles is validated through fluorescence microscopy. GUVs ranging from 10 µm to 60 
µm have been successfully synthesized using this method. The incorporation of both 
cholesterol and a negatively charged phospholipid in the membrane, and the use of mixed 
fatty-acid appended phospholipids were found to be essential for GUV formation. 
However, the gentle hydration method was not found to be a reproducible method, as 
only about 14% of the syntheses produced desired quantities of GUVs. This work has 
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 One of the most studied parts of the cell is the cellular membrane. The fluid 
mosaic model of the membrane has been used to explain membrane composition and 
architecture. The idea of the membrane being mosaic states that membrane components 
can remain side by side without reacting and forming a different substance, while fluid 
means that these molecules can float along the membrane to new locations as needed 
(Figure 1).1 The components of the membrane include carbohydrates, proteins, and 
phospholipids. Carbohydrates, which are covalently attached to various proteins and 
sphingolipids, extend to the outside of the membrane and act as tags for cell signaling. 
There are proteins embedded in the membrane lipid bilayer which have designated 








Figure 1: Fluid mosaic model of a cellular membrane showing different components1 
 
The bilayer is made up of polar phosphate-substituted heads on a glycerol 
backbone and non-polar fatty acid tails. The tails line up to form the hydrophobic interior, 
while the heads constitute the hydrophilic exterior. Due to these distinctions, these 
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molecules are called glycerophospholipids. There are many different types of 
glycerophospholipids, but the four most common that make up cellular membranes are 
phosphatidylethanolamine (PE), phosphatidylcholine (PC), phosphatidylserine (PS), and 
phosphatidylglycerol (PG), whose structures are given in Figure 2. Glycerophospholipids 













Phosphatidylglycerol (PG) –CH2CH(OH)CH2OH 
 
Figure 2: Common glycerophospholipid structures 
 
Membrane lipids are distributed asymmetrically between inner (cytosolic) and 
outer (exoplasmic) leaflets of the membrane (Figure 3), and vary among cell types. For 
example, in human erythrocytes (red blood cells), PS composes about 10% of total 
phospholipid in the inner membrane leaflet. PE, making up about 30% of total 
phospholipid, is predominately found in the inner leaflet. PC dominates in the outer 
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leaflet, composing about 30% of total phospholipids in the erythrocyte membrane.3 PG is 
very abundant in all bacterial membranes; however, in eukaryotes it is mostly found in 
the mitochondrial membrane. There are a few other phospholipids that compose the cell 
membrane as well, including phosphatidylinositol (PI), present mostly on the exoplasmic 
face and sphingomyelin (SM), present more on the cytosolic face. Cholesterol (CL) 
generally is present in equal amounts on both faces on the membrane. This asymmetric 










    Figure 3: Asymmetric distribution of membrane lipids in erythrocytes4 
 
The asymmetric nature of the cell membrane is an important concept to a number 
of applications, including different diseases like cancers. In cancerous cell membranes, 
the lipid composition of the membrane may change to encourage cell proliferation to 
avoid apoptotic signaling. For example, Llado et al. suggests that changed membrane 
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asymmetry of lipids may be associated with the malignancy of cancer tumors. Certain 
lipids such as ceramide or sphingomyelin that are typically responsible for signaling 
pathways in apoptosis can be significantly reduced in cancerous cell membranes.5 
All of these phospholipids are synthesized on the cytosolic face of the smooth 
endoplasmic reticulum (ER). Coenzyme A transfers fatty acids to glycerate-3-phosphate 
by a membrane bound enzyme. The resulting phospholipid, phosphatidic acid, is inserted 
into the ER membrane, and other enzymes on the cytosolic face of the ER membrane 
catalyze the addition or transformation of the different polar head groups. Since newly 
synthesized phospholipids are only added to the cytosolic face of the ER, some of these 
must be transferred to the lumenal or inner face of the ER to achieve the desired fluidity 
and dynamic activity of that portion of the cell membrane. In order to pass the polar head 
groups through the membrane, integral membrane proteins called flippases catalyze the 
rapid translocation across the membrane. The smooth ER is also the major site of 
cholesterol synthesis and other sterol derivatives.4  
 
Another molecule that is important to membrane composition is cholesterol. 
Cholesterol, a type of steroid, exists in the membrane either to add order and rigidity or to 
add fluidity, depending on the type of phospholipid and identity of its tails. Since 
cholesterol is highly hydrophobic, it is found embedded in the lipid tail region of the 
membrane.6 Cholesterol (Figure 4) generally makes up about 30-40 mol % of the plasma 
membrane, and is thought to be evenly distributed in the inner and outer leaflets. If the 
cellular membrane has an elevated amount of phosphatidylcholine lipid, to which 
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cholesterol has a high affinity, cholesterol may exist in greater amounts in the outer 







Figure 4: Structure of cholesterol 
Membrane lipids, such as phospholipids and cholesterol, are transported to the 
cell membrane after first being transported to the ER. One transport protein in particular, 
STARD4, is linked to cholesterol transport and homeostasis between the plasma 
membrane and ER membrane.7 Another way that cholesterol becomes incorporated into 
the plasma membrane is through the uptake of cholesterol via low density lipoprotein 
(LDL) receptors. LDL molecules carrying cholesterol bind to the receptors on the cell 
surface and are brought into the cell through clathrin-dependent endocytosis. Once inside 
the cell, this complex becomes an early endosome vesicle, and is then directed to the ER, 
which eventually directs cholesterol for incorporation into the plasma membrane.8 
All of these molecules together compose the lipid membrane of the cell. There are 
also particular groupings of lipids and membrane proteins which exist, known as 
microdomains. One type of microdomain, called a lipid raft, is of particular interest. 
Lipid rafts are very small, about 10-200 nm, highly heterogeneous, and dynamic.9 These 
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rafts consist mostly of packed glycosphingolipids and cholesterol that associate laterally 
through weak noncovalent interactions between carbohydrate head groups. Due to these 
interactions, they are also highly dynamic, rapidly exchanging both proteins and lipids 
laterally with their surrounding membrane components.6 Component lipids can exchange 
with bilayer lipids in a very short amount of time (1-10 s) or over much longer periods of 
time for those that are very tightly bound to different proteins.9 The plasma membrane’s 
asymmetry can be stabilized by the interaction of the lipids with other structures at the 
membrane surface such as the cytoskeleton, or by ionic and pH gradients across the 
membrane.10 Lipid rafts may have important functions including membrane trafficking 
and cell signaling.11 The asymmetric placing of these molecules somehow contributes to 
their overall purpose, and scientists are invested in studying cellular membranes to 
discern these exact functions. 
 One way to study and learn more about these biological assemblies is through the 
synthesis of liposomes. Liposomes are spherical, aqueous-filled bilayered vesicles which 
are produced by systematically mixing specific lipids or lipid mixtures. They range in 
size: giant unilamellar vesicles (GUVs) are 1-100 μm,12 and are also much larger than 
nanometer-sized liposomes like small unilamellar or large unilamellar vesicles (SUVs or 
LUVs). SUVs tend to be smaller than 100 nm in size, while LUVs range from 100-1000 
nm.13 GUVs are unique in that they are able to hold a larger volume of a desired buffer or 
drug solution than SUVs or LUVs. SUVs and LUVs also have higher membrane 
curvature, which can negatively affect lipid packing.14 GUVs have a membrane curvature 
more similar to that of cells, and are thus more useful as cell membrane mimics.14-15 In 
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the process of forming vesicles, multilamellar vesicles (MLVs) consisting of several 
bilayers, or multivesicular entities containing several vesicles within the largest one can 
also form. These vesicles are less suitable for experimental studies due to the lack of 
available volume caused by the extra bilayers (Figure 5). When MLVs form, there is no 
way to control the total number of bilayers within the largest vesicle.16 
 
Figure 5: Illustrations of different types of vesicles in terms of size and lamellarity16 
 
There are many proposed applications of giant unilamellar vesicles. Since GUVs 
are greater in size relative to LUVs or SUVs, they are useful in visualizing the dynamic 
behavior of the membrane under the microscope.15 They can also be manipulated by 
optical tweezers or micropipettes to examine properties such as membrane stability and 
elasticity. These micropipettes can also be used to administer extracellular substances to 
probe membrane lysis.13, 15 GUVs can mimic cell membrane functions such as transport 
and signaling. Due to their ability to model the cell membrane, they are also used to study 
membrane-protein interactions, as well as DNA-membrane interactions.17 By 
synthesizing vesicles with integral membrane proteins,18 including antibodies, or 
immunoglobulin moieties embedded within the membrane, liposomes can have specific 
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affinities to receptors on the target cell.19 Liposomes designated for target cells follow 
different mechanisms. 
Ostro and Cullis hypothesized that liposomes could interact with cells in a variety 
of ways, including adsorption, endocytosis, lipid exchange, and fusion (Figure 6).20 In the 
process of adsorption, free floating liposomes release their contents slowly into the 
extracellular fluid so that they can cross through the membrane into the cell cytosol. 
Liposomes can also be endocytosed, meaning that a piece of the cell membrane would 
pinch inward to bring the encapsulated molecule into the cytosol. Afterwards, undigested 
particles from inside the liposome are excreted into the cytoplasm. Not all cell types will 
exhibit this behavior; it is mostly seen in white blood cells, monocytes, and macrophages. 
Monocytes and macrophages are typically found in the liver, spleen, lymph nodes, bone 
marrow, and lungs. Another type of liposome-cell interaction is lipid exchange. In this 
process, individual lipids are exchanged by the cell membrane and liposome, without 
releasing any of the aqueous solution within the liposome. This exchange type is 
especially helpful for transport of a lipophilic drug to a target cell. The drug would need 
to be embedded within the liposome membrane rather than incorporated within the 
aqueous interior in order to reach the target cell. Finally, it is possible that liposomes 
could fuse with the cell membrane of interest in order for the liposome’s contents to be 
deposited directly into the cytoplasm of the cell. All of these methods are still being 
evaluated, as there are multiple avenues for liposomes to deliver their cargo. Once inside 













Figure 6: Types of liposome-cell interactions proposed by Ostro and Cullis20 
 
Due to the variety and complexity of the ways liposomes can interact with cell 
membranes, scientists are especially interested in synthesizing GUVs for their possible 
use as pharmaceutical delivery devices into diseased cells. Water-soluble drugs can be 
incorporated within the internal aqueous buffer that would eventually be encapsulated 
within the vesicle. Lipid-soluble drugs can be incorporated within the lipid membrane by 
mixing the drug with the lipid mixture to form a lipid film containing the drug.20 Since 
liposomes are able to pass through the intestinal barrier and carry their contents directly 
into the bloodstream, encapsulating drugs and other nutrients within the vesicle can 
significantly increase absorption rate. For example, there are now liposomal formulations 
such as Liposomal Vitamin C, which in a recent study by Davis et al., was shown to 
increase the absorption rate as compared to the rate of the traditional oral tablet. Other 
advantages of liposomal encapsulation include increased stability of the pharmaceutical, 
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protection from the gut’s possible irritating agents, and greater bioavailability of the 
drug.21 Currently there are a few types of medicinal liposomal formulations including the 
antitumor drug, doxorubicin and the antifungal drug, amphotericin B. Antibiotics 
contained within liposomes enable their antibacterial activities to be increased, as well as 
reduce potentially toxic side effects during antibiotic therapy.19 Some high-strength 
antibiotics are only used as a last resort due to high risk of severe side effects. However, 
if liposomal formulations containing these antibiotics were produced, patients could be 
treated for these types of bacterial infections without a high risk of side effects, as the 
liposome would be able to deliver the antibiotic to the site of infection. In addition, it may 
be possible to use these vesicles in a sustained and gradual release of drugs into the 
body’s circulation, which would reduce the amount of doses usually needed by free 
antibiotic drugs.19 
 Forster et al. investigated the possibility of using liposomes in peritoneal dialysis 
as a way to remove waste and toxic products from patients’ bloodstream. In peritoneal 
dialysis, special fluid with water and certain salts is placed within the abdomen to absorb 
any waste products within the bloodstream. The fluid is then drained away and the blood 
is “cleaned”. In the study, the dialysis solution contained liposomes with a 
transmembrane pH gradient to allow the toxic compounds to pass through the bilayer 
membrane and into the vesicle. This concentrates any toxic compounds within the 
vesicle’s interior, thus increasing the efficiency of the dialysis method. These researchers 
hoped this method could be applied to treat or remove various toxins from the body.22 
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Though the potential applications of using giant vesicles are exciting, there are 
several drawbacks. The exact mechanism of the vesicle formation is still unknown. 
Perhaps the most significant challenge is the lack of agreement on the best method and 
experimental conditions needed for forming a high yield of giant vesicles. In some of 
these procedures, GUV formation is only possible when using buffers with very low      
(< 10 mM) salt concentrations, as certain types of monovalent and divalent cations can 
interact with the charges on zwitteronic or negatively charged phospholipids, altering the 
formation of the vesicles. Other issues that have arisen among studies include the 
differences in size heterogeneity as well as degree of lamellarity of vesicles formed.23  
Several different methods of forming GUVs are known. The two most common 
include the electroformation method and the gentle (slow) hydration of a lipid film. The 
electroformation method was first developed by Angelova and Dimitrov in 1986.24 This 
procedure yielded many GUVs, yet used expensive equipment and lipid components. 
They used indium tin oxide coated electrodes, costing around $200 a pack,23 as well as a 
function generator to generate the electric current, which can cost anywhere from $300 to 
$2000.25 Since some laboratories do not have access to these resources, our research 
group strived to find a more inexpensive method. Dimova et al. noted the 
electroformation method is less effective in the presence of elevated salt concentrations 
of 100 mM or higher, as the electric current becomes over-amplified in the presence of 
cations.26 
The gentle hydration method was first performed by Reeves and Dowben in 1969. 
Phospholipids were placed in an Erlenmeyer flask with chloroform and methanol. The 
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organic solvent was evaporated under N2, leaving an even lipid film on the bottom of the 
flask. The flask was then placed under a vacuum to remove trace amounts of organic 
solvent. Then, the lipid film was pre-hydrated with water-saturated N2, and finally 
aqueous buffer containing sugar and a fluorescent dye was added down the sides of the 
flask. After swelling for two hours, white suspension of vesicles formed on the surface of 
the solution. However, not only were these vesicles extremely fragile, but many were 
misshapen and multivesicular.27 Needham and Evans synthesized GUVs in 1988. This 
group spread the lipids evenly on a Teflon disk, placed the disk under vacuum to remove 
organic solvent, pre-hydrated the lipids with water-saturated argon gas, and hydrated 
them with distilled water. This group produced a greater amount of unilamellar vesicles 
as compared to Reeves and Dowben, and also added a high mole percentage of 
cholesterol (ranging from 12.5-50 mole %) to the lipid mixture to enhance GUV 
formation.28 Furthermore, this group was the first to carry out the pre-hydration step at an 
elevated temperature of 35°C, which subsequent research groups stated as extremely 
necessary for GUV formation.26, 29-31 While the researchers did not elaborate on their 
decision to use Teflon instead of glass, later scientists followed suit using Teflon as well. 
Since Teflon is highly hydrophobic, perhaps it promotes more even spreading of a 
continuous lipid film. Once hydration begins, an aqueous layer would separate the bottom 
of the glass surface from the lipid layer, and the film would detach.  
This method was greatly improved upon by Akashi et al. in the late 1990s. In this 
work, the lipids were dried under rotary evaporation in a 10 mL test tube. The lipid film 
was pre-hydrated at 45°C and then hydrated with aqueous buffer in an oven at 37°C for at 
13 
 
least 24 hours. This extra time allowed vesicles to form more completely. Results of this 
study yielded vesicles that were spherical in nature and were mostly unilamellar, yet 
varied greatly in size from 25 to 300 μm (Figure 7).29-30 In addition to these new 
conditions, the lab group also reported that adding at least 10 mole % of charged lipids 
was essential for proper GUV formation. The repulsion of the charges between lipid 
bilayers was hypothesized to separate the dried layers and increase the normal force for 
vesicle formation during hydration. Additional research groups have affirmed the need 
for incorporation of charged lipids.31-33 Another specific application for adding negatively 
charged lipids such as phosphatidylserine or phosphatidylglycerol to the lipid 
composition is that they could enhance the encapsulation efficiency of positively charged 








Figure 7: Giant unilamellar vesicles formed through gentle hydration 
by Akashi et al in 199630 
 
An extremely important factor throughout the GUV synthesis process is the 
temperature. Many of the steps of the synthesis call for elevated temperatures, such as 
14 
 
during rotary evaporation, pre-hydration, and incubation. This elevated temperature is 
generally above the transition temperature of the lipid. When a mixture of lipids is used 
for a synthesis, it is important to use the highest transition temperature of all the 
individual lipids used in the mixture. The transition temperature is the temperature 
needed to change the state of the lipid from the ordered gel phase with fully extended, 
tightly packed hydrocarbon chains, to the liquid phase, where the hydrocarbon chains are 
randomly oriented and more fluid. Two factors that affect the transition temperature of a 
lipid, are the length of the hydrocarbon chain and the degree of unsaturation. If the chain 
length is increased, the Van der Waals interactions also increase and raise the transition 
temperature. If there is a higher degree of unsaturation in the chain, there is a 30° kink in 
the chain which decreases the packing and affords a lower transition temperature.18  
During the rotary evaporation step, the temperature should range from 45-55°C to 
create the most uniformly-spread lipid film. Morales-Penningston et al. have affirmed 
that a temperature above 45°C is necessary to heat the lipid film during the pre-hydration 
step as well.33 Avanti Polar Lipids, the major supplier of lipids used in this study, 
suggested preheating the internal buffer to be enveloped by the GUVs for proper swelling 
to occur.34 During the swelling step, vesicles should incubate at a temperature higher than 
the transition temperature of the lipid mixture,35 but not to the point of excessive heating, 
where it is possible for oxidation and free radical chain reactions to occur causing 
degradation of the lipids.33 Lipid peroxidation and lipid breakdown occur most readily 
with polyunsaturated lipids, and lead to changes in permeability, fluidity, and stability of 
cell membranes.36 For this reason, it is also important that the lipid solution be contained 
15 
 
in a vessel sealed with N2 to eliminate the presence of O2 during the swelling process. 
Increasing the temperature of GUV solutions can also induce budding or other shape 




Figure 8: Shape transformations induced by an increase in temperature14 
 
The proposed scientific protocol of vesicle formation is as follows: Lipids are 
dissolved in an organic mixture, usually chloroform and methanol,26 and placed on a 
rotary evaporator with a water bath set to an elevated temperature above the highest 
transition temperature for the types of lipids used. By evaporating off the organic solvent 
while rotating the round bottom flask, a uniformly-spread lipid film should form on the 
bottom of the flask. If the film appears dull, it is too thick, and if the film appears patchy, 
it is non-uniform.31 A thinly spread film with a large surface area is essential for GUV 
formation, since it appears that the GUVs form mostly on the exterior surface of the lipid 
film. The lipids that are within the layers of the film form long, thin, bilayer tubes, lipid 
artifacts, and multivesicular or multilamellar vesicles.32 In addition, chains of very small 
vesicles can form as well. These chains are tubular structures that can often exist within 
the vesicles.37 The “lipid network” that forms from these tether-like tubes has been 
reported to form regardless of phospholipid chain length.35 
After creating the film, it is placed under a vacuum anywhere from three to 
eighteen hours to ensure all traces of organic solvent have evaporated. It is important that 
16 
 
the lipid film be completely free of organic solvent before the hydration step, since 
residual solvent impedes effective GUV formation.16 The film is then pre-hydrated with 
water-saturated N2 above the transition temperature. Since lipid films are very easily 
dislodged, it is important that the hydration step is very gradual, and this pre-hydration 
step helps to ease the film off the glass material.38 Finally, it is hydrated with an aqueous 
buffer in order to swell the lipid bilayers to spontaneously vesiculate and encapsulate the 
solution. Due to the amphipathic nature of phospholipids, upon exposure to water, the 
hydrophobic tails associate and the hydrophilic head groups orient towards the water 
phase, which leads to a bilayer formation.20 One illustration of this swelling process can 























       Figure 10: Depiction of gentle hydration vesicle swelling from Mertins et al.39 
 
Once hydration begins, some form of electrostatic repulsion between bilayers is 
necessary in initially separating and keeping bilayer membranes apart.30 A multitude of 
research groups believe that incorporating charged lipids into the lipid membrane is 
essential for causing enough charge repulsion between lipid layers to separate them from 
the overall dried lipid film.29-33 Furthermore, the charge on the surface of liposome 
bilayers may also prevent aggregation or fusion and enhance GUV stability.40 After 
incubation at an elevated temperature (above the highest transition temperature of all 
lipids in the mixture) for a certain period of time (hours to days), GUVs should be visible 
as a white cloudy substance floating in the solution. 
After obtaining vesicles, scientists can visualize and confirm GUVs were 
synthesized using both white light and fluorescence microscopy. When studying 
properties of dynamic membrane structure, fluorescence microscopy has been cited as 
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one of the more reliable techniques due to its high sensitivity.2 It is important that the 
apparent vesicles under white light be also viewed under ultraviolet (UV) light to affirm 
that the vesicle has encapsulated the buffer containing a fluorophore. One major concern 
for applications in drug delivery is the encapsulation efficiency of the vesicles. Therefore, 
incorporating the fluorophore helps to discern if the aqueous solution is being taken up 
into the vesicle. If the entire spherical species fluoresces under UV light, vesicle 
formation and buffer encapsulation can be verified and distinguished from air bubbles 
and other lipid artifacts that may look like GUVs under white light. Research groups have 
also incorporated small percentages (~1 mole %) of fluorophore in the original lipid 
mixture so that the dye is incorporated in the hydrophobic lipid membrane.32 In this way, 
it would be expected for the outline of the vesicle to fluoresce under UV light. The 
fluorescent dye used in our lab group was the aqueous-soluble calcein disodium salt 
(Figure 11). The excitation wavelength for calcein is 495 nm and the emission 
wavelength is 515. The calcein was included in the aqueous buffer to be entrapped within 
the GUVs. This allowed for viewing of the GUVs under fluorescein isothiocyanate 
(FITC) light filters on the fluorescence microscope. Once a GUV was observed in white 
light, it was analyzed under UV light using a FITC filter to make sure the entire sphere 









Figure 11: Structure of calcein disodium salt 
 
The aim of this research is to develop a reproducible procedure to afford 
sufficient GUV yield in a short amount of time with relatively low cost. Gentle hydration 
was the primary method of GUV formation followed for this synthesis. Both natural 
phospholipids (those derived from the isolation of the lipid from natural sources) as well 
as synthetic phospholipids (those engineered with specific fatty acids appended to the 
phosphoglycerol backbone) were utilized.  
The natural types, including L-α-phosphatidylcholine (PC) from soy and 
phosphatidylglycerol (PG) from chicken egg, were the first lipids used to synthesize the 
giant unilamellar vesicles. For PC isolated from soy (PCsoy), there is a distribution of 
different fatty acids (as delineated in Figure 12) composed of a mixture of saturated and 
unsaturated species. For example, about 63% of the lipids have fatty acid chains with 
lengths of 18 carbon atoms and two unsaturated bonds, while 14.9 % of the lipids have 
fatty acid chains with lengths of 16 carbon atoms and no unsaturated bonds. If completely 
known distributions were desired, such as PC containing only one type of FA at the #1 
position, and one type of FA as the #2 position, purchasing them readily made would cost 
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hundreds to thousands of dollars for just milligram amounts of those specific lipids. 
While it would be better to have a completely known lipid distribution instead of a 









     




Both the space-filled (Figure 13) and the line structure (Figure 14) diagrams 
depict the structure of the main lipid component found in PCsoy. All of the four common 
phospholipids include the phosphate group attached to the #3 carbon of glycerol, with the 
two remaining glycerol carbon atoms attached to a variety of fatty acids via ester 
linkages. For phosphatidylcholine, the phosphate group is connected through an ethyl 
spacer to a nitrogen atom with three methyl groups, called the head group. By changing 
the head group, different types of phospholipids are formed. Biologically, saturated fatty 
acids tend to occupy the #1 position, while unsaturated fatty acids are present at the #2 
position. However, for the predominant species (about 63% 18:2 distribution) of PCsoy 
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Figure 13: Space-filled structure of main species (18:2) of PCsoy obtained from  





Figure 14: Structure of main species (18:2) of PCsoy obtained from  
Avanti Polar Lipids41 
 
The other type of phospholipid used in this work was phosphatidylglycerol 
extracted from chicken egg (PGegg), which is a negatively charged lipid. Both the space-
filled (Figure 15) and the line structure (Figure 16) diagrams depict the structure of the 
predominant species in PGegg. The glycerol group is seen attached to the phosphate at the 
head of the molecule, as seen in the boxed portion. In addition, this lipid is typically 










Figure 15: Space-filled structure of main species (16:0, 18:1) of PGegg 
 obtained from Avanti Polar Lipids42 
 
 
Figure 16: Structure of main species (16:0, 18:1) of PGegg 
 obtained from Avanti Polar Lipids42 
 
For PGegg, there is also a distribution of different fatty acids (Figure 17) composed 
of a mixture of saturated and unsaturated species. The two main types of PGegg in the 
mixture are 16:0 and 18:1. About 32.9% of the lipids will have each fatty acid chain with 
lengths of 16 carbon atoms with no unsaturated bonds, and 30.2% of the lipids will have 














Figure 17: Fatty acid composition of PGegg from Avanti Polar Lipids
42 
 
Four synthetic phospholipids with specific fatty acid chains esterified to the 
glycerol backbone were used. These included 1,2-dipalmitoyl-sn-glycero-3-
phosphatidylcholine (16:0 phosphatiylcholine or DPPC), 1-palmitoyl-2-oleoyl-sn-
glycero-3-phosphatidylcholine (16:0-18:1 phosphatidylcholine or POPC), 1,2-distearoyl-
sn-glycero-3-phosphatidyl-(1'-rac-glycerol) (18:1 phosphatidylcholine or DOPG), and 1-
stearoyl-2-oleoyl-sn-glycero-3-phosphatidyl-(1'-rac-glycerol) (18:0-18:1 or SOPG). 










Figure 18: Structure of 1,2-dipalmitoyl-sn-glycero-3-phosphatidylcholine, 16:0 






Figure 19: Structure of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphatidylcholine 16:0-18:1 







Figure 20: Structure of 1,2-distearoyl-sn-glycero-3-phosphatidyl-(1'-rac-glycerol), 18:1 





Figure 21: Structure of 1-stearoyl-2-oleoyl-sn-glycero-3-phosphatidyl-(1'-rac-glycerol), 






 In addition to changing the ratios of phospholipids used to synthesize GUVs, the 
amount of cholesterol can also be varied. Changing the amount of cholesterol could either 
increase or decrease membrane rigidity, depending on the degree of unsaturation in the 
fatty acid chains of the phospholipids. Normally, unsaturated bonds on the fatty acid 
chain make the bilayer more fluid. Since the soy PC isolate that will be used in the work 
contains mainly an 18:2 unsaturated species, adding cholesterol could add rigidity.1 This 
addition of cholesterol may aid in better formation or stability of GUVs. One challenge of 
determining the amount of cholesterol needed for incorporation within the GUV 
membrane is that when using a phospholipid species composed of a mixture of fatty 
acids, it is harder to elucidate the correct amount of cholesterol needed to control the 
degree of fluidity.  
Another important matter to consider is the size of the vesicles produced. The 
gentle hydration method tends to produce vesicles with a heterogeneous size distribution. 
However, most applications of GUVs would require vesicle populations of a similar size. 
A difference in vesicle size could result in differences in individual stability of the 
vesicles, the volume of substance encapsulated within the vesicle, curvature of 
membranes, rates of transport across membranes, and others distinctions.16 One of the 
goals of this project is to evaluate a variety of synthesis conditions which would generate 
the most consistent and homogenous production of GUVs. 
All of these points were carefully considered before selecting a method for 
forming giant unilamellar vesicles. In this research project, GUVs were formed from the 
gentle hydration method. The ratios of lipids used to make these GUVs 
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(phosphatidylcholine, phosphatidylglycerol, and cholesterol) were varied to determine the 
optimal amounts of lipid for sufficient vesicle yield. Other reaction conditions such as 
length and temperature of hydration incubation, type of swelling material, uniformity of 
lipid film, length of pre-hydration step, and time under vacuum were also tested for their 
effects on vesicle formation and stability. The results of this study will be explained 
qualitatively, with photographs of different vesicle solutions under white light and UV 



















Reagents and Supplies: 4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic acid, N-(2-
Hydroxyethyl)piperazine-N′-(2-ethanesulfonic acid) (HEPES) buffer (Sigma), Sodium 
Hydroxide pellets (Fisher), 1 M Sodium Hydroxide solution (Fisher), Calcein Disodium 
Salt (Fluka), Anhydrous Magnesium Chloride (Amresco), Sucrose (Fisher), D (+) 
Glucose (Acros), 3 M Hydrochloric Acid (Fisher), Methanol (Fisher), Chloroform 
(Fisher), Cholesterol (Sigma) 
 
The following lipids were purchased from Avanti: Soy (95%) L-α-phosphatidylcholine, 





Instrumentation: G3 Heidloph Rotary Evaporator/Hei-VAP Value “The Collegiate,” 
Fisher Scientific Marathon 26Km Centrifuge, Nikon Eclipse 80i with X-cite 120 
Fluorescence Illumination System, Nikon Digital Sight DS-U3 Camera, NIS Elements 
Imaging Software, Welch Vacuum 115V, 1510 Bransonic Ultrasonic Cleaner, Scientific 
Products Temp-Blok Module Heater, Avanti Polar Lipids Mini-Extruder, Fisher Vortex 
Genie 2, Chicago Surgical and Electrical Company Oven, FisherScientific Accumet 




Gentle Hydration-Preparation of Lipid Mixture 
 All micropipettes or glassware used with lipid solutions was first rinsed with 
chloroform. In a small vial, lipids were dissolved in 2 mL of a 2:1 (v/v) chloroform 
methanol solution. Specific molar ratios and amounts of each type of lipid were used to 
make the final solution (Table 1). Generally, about a 0.1 M solution of lipid solutions 




   Table 1: Specific types of lipids utilized with molar ratios, amounts, and concentration 






PCsoy, cholesterol 7.8:1.0 
15.5 mg PCsoy 
1.0 mg cholesterol 
 
-- 
PCsoy, cholesterol 7.8:2.0 
15.5 mg PCsoy 
2.0 mg cholesterol 
-- 
 
PCsoy, cholesterol 9.0:1.0 
17.8 mg PCsoy 
1.0 mg cholesterol 
-- 
PCsoy, cholesterol 9.0:2.0 
17.8 mg PCsoy 
2.0 mg cholesterol 
-- 
PCsoy, PCegg 7.8:1.0 
15.5 mg PCsoy 
200 µl PGegg 
 
10 mg/mL PGegg 
PCsoy, PCegg, cholesterol 7.8:1.0:1.0 
15.5 mg PCsoy 
200 µl PGegg 
1.0 mg cholesterol 
 
10 mg/mL PGegg 
PCsoy, PCegg, cholesterol 7.8:1.0:2.0 
15.5 mg PCsoy 
200 µl PGegg 
2.0 mg cholesterol 
 
10 mg/mL PGegg 
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PCsoy, PCegg, cholesterol 8.4:1.0:19.8 
15.5 mg PCsoy 
200 µl PGegg 
20 mg cholesterol 
 
10 mg/mL PGegg 
PCsoy, PCegg, cholesterol 9.0:1.0:2.0 
17.8 mg PCsoy 
200 µl PGegg 
2.0 mg cholesterol 
 
10 mg/mL PC 
16:0 PC, cholesterol 9.0:1.0 
200 µL PC 
10 µL cholesterol 
25 mg/mL PC 
16:0 PC, 18:1 PG, 
cholesterol 
9.0:1.0:1.0 
200 µL PC 
60.3 µL PG 
10 µL cholesterol  
25 mg/mL PC 
10 mg/mL PG 
16:0 PC, 18:0-18:1 PG, 
cholesterol 
9.0:1.0:1.0 
200 µL PC 
60.5 µL PG 
10 µL cholesterol 
25 mg/mL PC 
10 mg/mL PG 
16:0-18:1 PC and 
cholesterol 
9.0:1.0 
200 µL PC 
10 µL cholesterol 
25 mg/mL PC 
 
When considering temperatures to carry out during each step of vesicle formation, 
the transition temperature of the phospholipid being utilized was considered (Table 2). 
These transition temperatures are specific to the phospholipid type, unless a mixed 
composition phospholipid was used. In that case, the most prominent fatty acid 







Table 2: Transition temperatures of phospholipids utilized43-44  
Type of Lipid Transition Temperature (°C) 





16:0 phosphatidylcholine 42 
16:0-18:1 phosphatidylcholine -2 
18:1 phosphatidylglycerol -18 
18:0-18:1 phosphatidylglycerol -10 
 
Gentle Hydration-Preparation of Internal Buffer to be Encapsulated by GUVs 
 Internal Buffer was prepared in a 125 mL Erlenmeyer flask, with a mixture 
containing 10 mM anhydrous MgCl2, 10 mM HEPES, 100 mM sucrose, and deionized 
water. To prepare a 100 mL solution with these proportions, 0.2383 g Hepes was added 
to the Erlenmeyer flask with 50 mL of dH2O. The solution was then adjusted to a pH of 
7.4 by adding 1 M NaOH dropwise. Then, 0.0952 g anhydrous MgCl2, and 3.423 g 
sucrose were added to the Erlenmeyer flask. Next, 10-100 µM of calcein disodium salt 
solution was added to the mixture. The flask was swirled to mix, and the pH was 
maintained at 7.4. The solution was then transferred to a 100 mL volumetric flask, where 
dH2O was added to the 100 mL mark. The final solution was a light yellow-green color. 
The flask was inverted to mix, then its contents were transferred to an amber bottle. The 
solution was stored at 4°C. 
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Gentle Hydration-Preparation of External Buffer 
 External buffer was prepared in a 300 mL Erlenmeyer flask, with a mixture 
containing 10 mM anhydrous MgCl2, 10 mM Hepes, 120 mM D (+) glucose and 
deionized water. A 300 mL solution with these proportions was prepared accordingly: 
0.7149 g Hepes was added to the Erlenmeyer flask with 200 mL of dH2O. The solution 
was then adjusted to a pH of 7.4 by adding 1 M NaOH dropwise. Then, 0.2856 g 
anhydrous MgCl2, and 6.486 g D (+) glucose were added to the Erlenmeyer flask. The 
flask was swirled to mix, and the pH was checked and adjusted to maintain a final value 
of 7.4. The solution was then transferred to a 300 mL volumetric flask, where dH2O was 
added to the 300 mL mark. The final solution was colorless. The flask was inverted to 
mix, then its contents were transferred to an amber bottle, stored in the fridge at 4°C.  
 
Gentle Hydration-Preparation of GUVs 
 All micropipettes or glassware to be used with lipid solutions was first rinsed with 
chloroform. One mL of 2:1 (v/v) chloroform/methanol was added to either a 100 mL or 
250 mL round bottom flask. Two hundred µl of the lipid mixture was added to the flask. 
The water bath of the rotary evaporator was set to 45°C and the rotary evaporator speed 
set to 100 rpm.33 The angle was also adjusted so that the flask would be positioned more 
vertically. After pulling vaccuo for one minute, a lipid film was formed at the bottom of 
the round bottom flask. Up to three individual evaporations for each trial were performed 
in order to obtain the most uniform lipid film. One mL of a 2:1 (v/v) chloroform/ 
methanol solution could be added to redissolve the lipid in the round bottom flask, and 
the organic solvent evaporated off two more times for a total of three evaporations. The 
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flask was then placed in a desiccator and vacuum was pulled for either three hours or 
overnight (about 18 hours) to remove traces of organic solvent. After vacuum, the lipid 
film was pre-hydrated with water-saturated N2 for at least 30 minutes in a 45°C water 
bath (Figure 22). Nitrogen is cannulated into a test tube containing dH2O. Then, water-
saturated N2 is cannulated into the flasks containing the lipid film to promote stripping of 
the film. Next, 5 mL of internal buffer containing the calcein fluorophore was added to 
the flask. The flask was sealed with N2. The flask was wrapped with aluminum foil to 
preserve the calcein from photo bleaching, then placed in an oven, with temperatures 
ranging from 35-47°C, for incubation. The flask was not disturbed at all while the 
swelling took place, as any agitation can disrupt the swelling process.26, 31 After 










Figure 22: Photograph illustrating pre-hydration step with cannula allowing water-
saturated N2 stream to pass into flasks and pre-hydrate lipid films 
dH20 






Gentle Hydration-Preparation for Microscopic Viewing 
Before microscope analysis, the contents of the flask were transferred with Pasteur 
pipettes in 1 mL aliquots into 1.5 mL microcentrifuge tubes. The tubes were centrifuged 
for 1 minute at 12,000 g. Immediately supernatant solution was transferred to new 
microcentrifuge tubes, to test if any GUVs were present floating in solution. One mL of 
external buffer solution was added to the tubes containing the pellet and these were 
centrifuged again for 10 minutes at 12,000 g. The difference in refractive indices from the 
sucrose in the internal buffer solution and the glucose in the external buffer solution 
allowed for better viewing under the microscope.29-30, 45 In addition, utilizing a 100 mM 
internal sucrose concentration versus the 120 mM external glucose concentration will 
avoid any osmotic pressure-induced bursting of GUVs.45 When observeing a supernatant 
sample, 10 µl was first added to the microscope slide as a means of diluting excess 
calcein in solution. About 10-20 µl GUV solution (either the supernatant or pellet) was 
placed into the external buffer on the microscope slide. A coverslip was placed on top, 
with one end touching the slide first to prevent air bubbles. Pictures were taken on the 









RESULTS AND DISCUSSION 
Determination of Pixel to Micron Conversion 
 One of the first goals of the project was to determine the conversion between the 
units of measure on the scale bar in the NIS Elements Camera software (pixels) to 
micrometers. To do this, a stage micrometer with 0.01 mm increments was placed on the 
microscope. The ruler was brought into sharp focus. Then the scale bar was virtually 
added on top of the ruler. A picture was taken of this setup (Figure 23 and 24). Estimates 
were then made that at 100x total magnification, 1000 px ≈ 225 μm. This number could 
be scaled down to find that 100 px ≈ 22.5 μm. At 200x total magnification, 1000px ≈ 
112.5 μm, and 100 px ≈ 11.25 μm. With this conversion, accurate measurements of the 
GUVs were able to be taken. The scale bars will appear throughout the paper on pictures. 











Figure 23: Pixel to micron 
conversion on ruler; 100x 
magnification 
Figure 24: Pixel to micron 




0.01 mm 0.01 mm 
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Table 3: Pixels to micrometer conversions at 100x and 200x total magnification 
 
After this size determination was made, 59 GUV syntheses with differing 
conditions were carried out following the gentle hydration procedure. The data for these 
trials was tabulated as a reference point for comparison, and can be found in Appendix A 
and B. 
 
Determination of Optimal Conditions for the Creation of Uniform Lipid Film 
 Many factors contribute to the creation of a uniform lipid film, including the 
rotations per minute and temperature bath on the rotary evaporator, the angle of the rotary 
evaporator, the type and size of vessel used in the evaporation, and the total number of 
evaporations. Throughout different GUV syntheses, these factors were varied in order to 
determine the optimal conditions for the most uniformly dispersed lipid film.  
  
Pixel Bar (px) 100x Magnification (μm) 200x Magnification (μm) 
1000 225 112.5 
500 112.5 56.25 
250 56.25 28.125 
200 45.0 22.5 
100 22.5 11.25 
50 11.25 5.625 
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For the speed of the rotary evaporator, it was determined that 50 rpm was too slow, 
and produced a film that was too concentrated on the bottom of the round bottom flask 
while a speed of 150 rpm caused the lipids and organic solvent to form a spiral-like film 
(Figure 25). The largest amount of uniform films was produced using 100 rpm (Figure 
26). After this distinction was made, most subsequent films were produced using 100 
rpm, unless dispersed film formation did not occur, in which case the speed was reduced. 
In some cases, when a different type of lipid with different transition temperatures were 











Research groups throughout GUV literature affirmed the need for the lipid film to 
be produced at a temperature higher than the highest transition temperature found within 
the lipid mixture. Our lab group verified that 45°C worked well for the formation of a 
uniform film. This temperature was selected by the suggestion of the Morales-
Penningston research article, which stated that GUV formation was the best when the 
Figure 25: Spiral-like lipid film formed 
from 150 rpm rotary evaporation  
(7.8:2.0 PCsoy, cholesterol) 
Figure 26: Very uniform lipid film formed 
from 100 rpm rotary evaporation 




temperature was within the range of 45-55°C, since the most commonly used lipid types 
have a transition temperatures just below this range.33 
 The angle of the rotary evaporator was varied to try to stop lipid rings from 
forming when evaporating the organic solvent. It was discovered that the angle could not 
be completely 90°, as the round bottom flask being completely vertical led to a highly 
concentrated lipid film of a very small diameter. The final angle that was selected for the 
best lipid film produced a film that was about 3.5 cm in diameter. The correct angle of 
the rotary evaporator can be seen in Figure 27. The angle sometimes had to be changed 
very slightly when using a ground glass connector for smaller opening (19/22) round 
bottom flasks, as the connector elongated the arm of the rotary evaporator and changed 











Figure 27: Rotary evaporator set to ideal angle for uniform lipid film formation 
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A few different vessels were used to evaporate off organic solvents and create the 
lipid film. For the most part, round bottom flasks were used. However since some 
research groups reported using a test tube for the evaporation,29-30 that method was tested 
by our lab as well. For the round bottom flasks, a variety of sizes were tried, including 50 
mL, 100 mL, and 250 mL flasks. After a few different attempts, it was determined that 
the 250 mL round bottom flask gave the most uniform lipid films, as the greater surface 
area in contact with the water bath led to more uniform spreading than the 50 or 100 mL 
flask. Glass test tubes (13 x 100 mm) were used to evaluate the test tube evaporation 
method. These attempts always led to the solvent evaporating violently, spattering lipids 
all over the sides of the test tube. Even when the speed and temperature were decreased 
significantly, uniform films could not be formed using a test tube. This film was formed 









Figure 28: Spattered lipid film obtained from test tube rotary evaporation  
(7.8:2.0 PCsoy and cholesterol) 
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 Finally, one research group, Rodriguez et al., reported the need for several 
evaporations, adding more organic solvent each time, in order to create the most uniform 
film.46 After a first unsuccessful evaporation yielded a non-uniform film or ring, more 
organic solvent was added, and a second or third evaporation could yield a uniform film. 
This method seemed to work better for films composed of phosphatidylcholine than for 
those composed of phosphatidylglycerol.  
 
Effect of Lipid Composition on Successful GUV Syntheses 
In each synthesis, the neutral lipid phosphatidylcholine was used. However, 
several different experiments were conducted varying the amount of the negatively 
charged phosphatidylglycerol and the amount of cholesterol. Overall, eight experiments 
yielded at least medium amounts of giant unilamellar vesicles. 62% of these trials 
contained phosphatidylglycerol within the lipid mixture used to synthesize the lipid film. 
These trials not only yielded a very high number of vesicles, but the majority of the 
vesicles obtained were unilamellar. Similarly, 88% of the trials which yielded relatively 
high amounts of GUVs contained cholesterol within the lipid mixture. These results 
suggest that the incorporation of phosphatidylglycerol and cholesterol are important in 
synthesizing a successful yield of GUVs. When discussing a successful GUV synthesis 
qualitatively, the relative amount of GUVs in solution will be referred to as small, 
medium, or large. A small yield of GUVs refers to vesicles being present in 25% or less 
of the solution viewed on the coverslip. A medium yield of GUVs refers to vesicles being 
present in about 50% of the coverslip. A large yield of GUVs refers to vesicles being 
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present in over 50% of the fields viewed on the coverslip. A few of the successful GUV 
syntheses will be discussed here, to identify optimized conditions as well as identify 
several challenges seen by these experiments. 
The first experiment with high GUV yield was composed of a lipid mixture that was 
7.8:1.0 PCsoy to PGegg. This mixture contained no cholesterol, but still yielded a fair 
amount of GUVs. Three evaporations were used to obtain the most uniform lipid film, 









Figure 29: Uniform lipid film obtained from 7.8:1.0 PCsoy PGegg lipids after  
three evaporations 
 
The flask was then placed in a desiccator vacuum for 3.5 hours to remove all traces of 
organic solvent. Next, the round bottom flask containing the lipid film was placed in a 
45°C water bath and pre-hydrated with water-saturated N2 for 30 minutes. After pre-
hydration, the flask was removed from the water bath and 5 mL of internal buffer 
solution containing the calcein fluorophore was added to the film. The solution was 
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incubated at 37°C for 2 days. After this time the flask was removed from the oven and a 











 Upon analysis under the microscope in both white light and UV light (FITC 
filter), a relatively large quantity of vesicles had formed. The relative amount of these 
vesicles that were unilamellar versus multilamellar or multivesicular was medium. The 
average size of the GUVs formed were about 10-25 μm. A sample photograph both in 
white light and UV light of the GUVs formed can be seen in Figure 31. 
 
 
Figure 30: White suspension formed in GUV solution after 2 days of incubation 






















Figure 31: White light and fluorescence photographs of GUVs at 100x magnification 
(7.8:1.0 PCsoy PGegg) *Some images throughout the paper have been brightened/enhanced for clarity 
 
100 px ≈ 22.5 μm  
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In a second successful GUV synthesis, the lipid mixture consisted of 7.8:2.0 PCsoy 
to cholesterol. This mixture contained no phosphatidylglycerol, but still yielded a large 
amount of GUVs. Three evaporations were needed to obtain a mostly uniform lipid film, 










Figure 32: Uniform lipid film obtained from 7.8:2.0 PCsoy cholesterol lipids after  
three evaporations 
 
This flask was placed in a desiccator vacuum for 3 hours to remove all traces of 
organic solvent. The round bottom flask containing the lipid film was then placed in a 
45°C water bath and pre-hydrated with water-saturated N2 for 30 minutes. After pre-
hydration, the flask was removed from the water bath and 5 mL of internal buffer 
solution containing the calcein fluorophore was added to the film. The solution was 
incubated at 37°C for 6 days. After this time the flask was removed from the oven and a 
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large amount of white suspension aggregated together in a string-like fashion was visible 










Figure 33: White suspension formed in GUV solution after 6 days of incubation  
(7.8:2.0 PCsoy cholesterol) 
 
 Upon analysis under the microscope in both white light and UV light (FITC 
filter), the quantity of vesicles formed and relative amount of unilamellar vesicles was 
large. The average size of the GUVs formed were about 10-25 μm, and the largest GUV 
spotted was about 56 μm. The largest GUV seen in white light and UV light in Figure 34, 
and a sample picture of the averaged sized GUVs can be seen in white light and UV light 







Figure 34: White light and fluorescence photographs of GUVs at 200x magnification 





































Figure 35: White light and fluorescence photographs of GUVs at 100x magnification 
(7.8:2.0 PCsoy cholesterol) 
 
100 px ≈ 22.5 μm  
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In another successful GUV synthesis, the lipid mixture consisted of 7.8:1.0:2.0 PCsoy 
to PGegg to cholesterol. Four evaporations were used but still the lipid was distributed in a 
ring-like film, shown in Figure 36. It was unusual that this lipid film formed in a ring-like 









Figure 36: Lipid ring obtained from 7.8:1.0:2.0 PCsoy PGegg cholesterol lipids  
 
This flask was placed in a desiccator vacuum for 4 hours to remove all traces of 
organic solvent. Next, the round bottom flask containing the lipid film was placed in a 
45°C water bath and pre-hydrated with water-saturated N2 for 40 minutes. After pre-
hydration, the flask was removed from the water bath and 5 mL of internal buffer 
solution containing the calcein fluorophore was added to the film. The solution was 
incubated at 41°C for 3 days. After this time the flask was removed from the oven and a 












Upon analysis in both white light and UV light (FITC filter), a relatively large 
quantity of vesicles had formed. In addition, most of the vesicles were unilamellar, not 
multilamellar. The average size of the GUVs formed were about 10-25 μm. A sample 
picture of the averaged sized GUVs can be seen in white and UV light in Figure 38.  
 
Figure 37: White suspension formed in GUV solution after 3 days of incubation 






















100 px ≈ 11.25 μm  
Figure 38: White light and fluorescence Photographs of GUVs at 200x magnification 
(7.8:1.0:2.0 PCsoy PGegg cholesterol) 
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 The lipid mixture of 7.8:1.0:2.0 PCsoy to PGegg to cholesterol remained the same in a 
fourth successful GUV synthesis. Only one evaporation was used to obtain a very 








Figure 39: Uniform lipid film obtained from 7.8:1.0:2.0 PCsoy PGegg cholesterol lipids  
 
The flask was placed in a desiccator vacuum overnight for a total of 18 hours to 
remove all traces of organic solvent. Next, the round bottom flask containing the lipid 
film was placed in a 45°C water bath and pre-hydrated with water-saturated N2 for 45 
minutes. After pre-hydration, the flask was removed from the water bath and 5 mL of 
internal buffer solution containing the calcein fluorophore was added to the film. The 
solution was incubated at 41°C for only 5 hours. After this time the flask was removed 
from the oven and a large amount of white suspension was visible floating in the solution 













Figure 40: White suspension formed in GUV solution after 5 hours of incubation 
(7.8:1.0:2.0 PCsoy PGegg cholesterol) 
 
Upon analysis under the microscope in both white light and UV light (FITC 
filter), a large relative quantity of vesicles had formed. Some of the GUVs observed were 
the most unilamellar and perfectly spherical vesicles synthesized to date. It was verified 
by observing that these vesicles under UV light that they had encapsulated the buffer, and 
the intensity of fluorescence was high. The average size of the GUVs formed were about 
10-25 μm. These GUVs can be seen at 100x and 200x total magnification in white light 





























100 px ≈ 22.5 μm  
Figure 41: White light and fluorescence photographs of GUVs at 100x magnification 























Figure 42: White light and fluorescence photographs of GUVs at 200x magnification 
(7.8:1.0:2.0 PCsoy PGegg cholesterol) 
200 px ≈ 22.5 μm  
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Another successful unique GUV synthesis was performed with a lipid mixture 
consisting of 8.4:1.0:19.8 PCsoy to PGegg to cholesterol. This trial was conducted to test if 
a very high mole % of cholesterol (67% in this case) could allow for successful GUV 
formation. Only one evaporation was used to obtain a very uniform lipid film with some 








Figure 43: Uniform lipid film obtained from 8.4:1.0:19.8 PCsoy PGegg cholesterol lipids  
 
This flask was placed in a desiccator vacuum for 3 hours to remove all traces of 
organic solvent. Next, the round bottom flask containing the lipid film was placed in a 
45°C water bath and pre-hydrated with water-saturated N2 for 30 minutes. After pre-
hydration, the flask was removed from the water bath and 5 mL of internal buffer 
solution containing the calcein fluorophore was added to the film. The solution was 
incubated at 41°C for 3 days. The flask was then removed from the oven and a very small 
amount of white suspension with flaky pieces was visible floating in the solution. In 
addition, there was still leftover film stuck to the bottom of the round bottom flask that 












Upon analysis in both white light and UV light (FITC filter), a relatively large 
quantity of vesicles had formed. In addition, most of the vesicles formed were 
unilamellar, not multilamellar. The average size of the GUVs formed were about 5-25 
μm. A sample picture of the averaged sized GUVs can be seen in white and UV light in 
Figure 45. Rectangular chunk artifacts were observed frequently when viewing this 







Figure 44: White suspension formed in GUV solution after 3 days of incubation 






















Figure 45: White light and fluorescence pictures of GUVs at 200x magnification 
(8.4:1.0:19.8 PCsoy PGegg cholesterol) 





 At this point in the experimental procedure, lipid mixtures were adjusted to give 
ratios of 9:1 neutral lipid to charged lipid, following literature precedent.29, 31-32 The next 
phase of experimentation examined the difference between using a mixed species of 
phospholipid against synthetic phospholipids with specific fatty acid chain composition. 
These types included 16:0 phosphatidylcholine (DPPC), 16:0-18:1 phosphatidylcholine 
(POPC), 18:1 phosphatidylglycerol (DSPG), and 18:0-18:1 phosphatidylglycerol 
(SOPG).  
 It was hypothesized that knowledge of the exact species of phospholipid 
composing the membrane would make it easier to study lipid membrane composition. 
However, formation of giant vesicles was unsuccessful using all attempted combinations 
of neutral and charged pure fatty acid phospholipids. After swelling in the oven for a 
typical amount of time such as 3 days, the flasks were removed and little to no white 
floating material was observed. An example of this can be seen from a synthesis made 








Figure 46: No observed white suspension in 16:0 PC, 18:1 PG, cholesterol synthesis 
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After centrifugation and workup of these types of vesicle solutions, no pellet was 
seen. Analysis under the microscope showed the formation of a very small amount of 
mostly multilamellar vesicles or no formation of vesicles at all.  
These synthetic phospholipid syntheses were unsuccessful; however, human cell 
membranes are made of many different types of phospholipids with varying fatty acid 
chain compositions so this result was not entirely out of order.4 This asymmetry and 
varied makeup of the membrane helps to stabilize the overall structure and has a 
substantial contribution to the operation of specific portions of the membrane. To try to 
make up for this difference, the experimental procedure was altered.  
Temperatures were modified to reflect those associated with the transition 
temperatures of the pure phospholipid fatty acid chains. For example, 16:0-18:1 PC, 
being unsaturated, has a transition temperature of only -2°C. While the predominant 
species in PCsoy phospholipids used in earlier experiments had higher transition 
temperatures and 45°C was typically used for experimental procedures requiring heating, 
it was theorized that this temperature was too high for formation of GUVs containing 
phospholipids with lower transition temperatures. Room temperatures were used for the 
pure phospholipid types with lower transition temperatures, in the rotary evaporation, 
pre-swelling with water-saturated N2, and incubation in oven steps, but these changes did 
not yield successful GUV formations either. Therefore, if our model hopes to mimic a 
true cell membrane, it makes sense that the vesicles would be more stable with varied 




Challenges in GUV Syntheses 
Several challenges were encountered when trying to improve the method of 
synthesizing giant unilamellar vesicles. In particular, these challenges were obtaining a 
uniform lipid film, obtaining a high amount of GUV swelling from the lipid film (as 
visualized in the white suspension formed after the hydration period), obtaining vesicles 
that were highly unilamellar rather than multilamellar, and discerning GUVs in white 
light. In addition, many unilamellar GUVs that formed were embedded within a lipid 
pellet, and we were unsuccessful in developing a viable method for breaking up this 
pellet without disturbing the stability of the GUVs. Different methods of sonication and 
vortexing were attempted over varied periods of time, but did not prove successful and 
ultimately ended up destroying the vesicle membranes. 
After determining optimized parameters, experiments were performed using a 
water bath temperature of 45°C, a rotation speed of 100 rpm, and an evaporation time of 
2 minutes on the rotary evaporator, yet not every trial generated a perfectly uniform lipid 
film. While these conditions did provide very uniform lipid films the majority of the time 
(~ 71% of all syntheses), there were still several trials where even multiple evaporations 
could not provide a uniformly-spread lipid film. Lipids rings were obtained in the cases 
when spread films could not be produced. When a ring was produced, the speed of 
rotation and temperature of the water bath were decreased in an attempt to create a more 
uniform film, but these endeavors usually failed. It is extremely important that the round 
bottom flasks be thoroughly rinsed with acetone and copious amounts of detergent and 
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deionized water between each trial, as any leftover film or contaminant could be leading 
to the failure to produce uniform films. 
Another problem that occurred within the GUV syntheses was that varied 
amounts of white suspension would be produced after a few days of hydration. Three of 
the most successful GUV experiments had large or very large amounts of white 
suspension to harvest vesicles from after the swelling period, yet two of the other 
successful syntheses had only a very minute amount of white suspension after hydration. 
It is therefore indeterminate whether the presence of a large amount of white suspension 
is indicative of successful GUV formation. Furthermore, many trials considered 
unsuccessful in the amount of unilamellar vesicles produced had a very large amount of 
white suspension floating in solution after the hydration period. The resulting species 
were usually composed of multilamellar aggregates. As an example, a synthesis made 
from a 7.8:1.0 PCsoy to PGegg lipid mixture produced a very large amount of white 
suspension after the hydration period as in Figure 47. However, these vesicles were 












Figure 47: Large amount of white suspension formed in GUV solution 
(7.8:1.0 PCsoy to PGegg) 
 
One of the biggest challenges was obtaining unilamellar vesicles. Many of the 
GUV trials produced vesicles that were mostly multilamellar or multivesicular. One 
example of a very defined multivesicular entity composed of 7.8:1.0 PCsoy and 
cholesterol is seen in Figure 48. Synthesis conditions such as production of the uniform 
lipid film and swelling conditions like temperature and time need to be changed further in 
















Figure 48: Multivesicular entity under white light at 200x magnification 
(7.8:1.0 PCsoy and cholesterol) 
 
 Great care must be taken when observing GUV solutions under the microscope, 
because a majority of the time the vesicles that are the most unilamellar and promising 
are those which seem almost invisible in white light. In the fourth successful synthesis 
mentioned before with the 5-hour incubation time, it was not until vesicles were viewed 
under UV light that those particular vesicles were found. After switching back to white 
light, the power source to the white light had to be diminished almost completely, to 
barely make out the membrane outline of the giant vesicles. Before assuming a vesicle 
synthesis trial is unsuccessful, the viewer must search the entire slide for GUVs in UV 
light as well as white light. 
 
 
200 px ≈ 22.5 μm  
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Observations Using Fluorescence Microscope with White and UV Light  
An interesting observation was made when viewing a particular vesicle in the 
third successful synthesis made from the 7.8:1.0:2.0 PCsoy to PGegg to cholesterol lipid 
mixture. It seems that UV light or the heat from this light has the capability to alter the 
morphology of a vesicle. A series of photographs in white light were taken (Figure 49). 
Panel 1 shows an oblong multivesicular entity as it was first seen under white light. Then, 
UV light through the FITC filter was shone for 20 seconds. Upon observation under 
white light again, the vesicle had condensed slightly and the smaller vesicles inside it 
seemed to flatten out (Panel 2). In Panel 3, 30 seconds more were allowed to pass under 
white light, and the vesicle membrane seemed to reform fully to a perfect sphere, even 
more spherical than its original structure. Panel 4 shows the product of shining UV light 
again for 20 more seconds: the vesicle has stretched out to an ovular shape again. Finally, 






















Figure 49: Light/heat-induced shape transformations of GUV depicting elastic 
properties at 200x magnification (7.8:1.0:2.0 PCsoy, PGegg, cholesterol) 
 
Another type of vesicle deformation observed was blebbing, in which it appears that a 
smaller vesicle is budding off of the larger one. One blebbling GUV was observed from 
the same GUV synthesis as the light-induced shape transformations, the 7.8:1.0:2.0 PCsoy, 
PGegg, cholesterol lipid mixture, but this vesicle solution was vortexed in order to try to 
break up the pellet. A series of pictures showing the blebbing GUV over a period of one 
minute can be seen in Figure 50. The blebbing GUV is seen in Panel 1, with the smaller 
vesicle appearing to be pulling away from the larger one. After shining UV light briefly 
and waiting 30 seconds, the larger GUV seems to have engulfed the smaller vesicle 
(Panel 2). Finally, after another 30 seconds passed, the larger GUV’s shape became 
ovular and the smaller vesicle was seen outside the larger vesicle once more (Panel 3). 
200 px ≈ 22.5 μm  
Panel 1 Panel 2 Panel 3 





Figure 50: Blebbing GUV shape transformations over time at 100x magnification 
(7.8:1.0:2.0 PCsoy, PGegg, cholesterol) 
 
 Different vesicle morphologies were observed in this work. Lipid tubules existing 
within giant vesicles were observed in a GUV synthesis composed of 7.8:1.0:1.0 PCsoy, 
PGegg, and cholesterol. (Figure 46). Lipid network tubes connecting smaller vesicles were 
observed as well in a GUV synthesis composed of 8.4:1.0:19.8 PCsoy, PGegg, and 









Figure 51: Lipid tubules within vesicle, 200x magnification  
(7.8:1.0:1.0 PCsoy, PGegg, and cholesterol) 
Panel 1 Panel 2 Panel 3 

























Figure 52: Network of lipid connecting vesicles 200x magnification 





Giant unilamellar vesicles were formed ranging in size from 10-56 μm, and their 
formation was verified using both white light and fluorescence microscopy. Several 
conditions were optimized allowing for better formation. For example, in the first step of 
the vesicle synthesis when creating a lipid film, it was determined that it is absolutely 
essential for a high yield of GUVs that the film be as thinly spread and uniform as 
possible. Most of the successful GUV trials had very uniform or mostly uniform films; 
usually ring-like or spotted lipid films yielded little to no GUVs.  
The most successful GUV syntheses (in terms of high yield of unilamellar 
liposomes) were achieved when the negatively charged PG lipid was part of the lipid 
mixture. This finding was consistent with other researchers that claimed that a charged 
lipid is essential in stable GUV formation. It is speculated that the incorporation of the 
negatively charged lipids promotes electrostatic repulsion between phospholipid heads, 
allowing for the vesicles to spontaneously form in the hydrated solution. However, some 
successful GUV formations could also occur without the presence of previously 
incorporated negatively charged lipids. In addition, mixed fatty acid-appended 
phospholipid species enabled better formation of GUVs than phospholipids with only one 
type of fatty acid chain, as all successful GUV syntheses were obtained using mixed 
species, and none (0 of 15) of the syntheses were successful using synthetic phospholipid 
species. 
Greater amounts of cholesterol within the lipid mixture led to higher GUV yields. 
Stable, unilamellar vesicles made from soy phosphatidylcholine and phosphatidylglycerol 
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could be produced with as high as 67 mole % of cholesterol in the lipid mixture. A 
possible theory to explain this result is that the main fatty acid species composing PCsoy 
(about 63%) has an 18:2 fatty acid chain. Membrane formation is likely more conducive 
when cholesterol is added to this polyunsaturated lipid, as it can increase the rigidity and 
packing of the membrane by filling in spaces caused by the higher degree of unsaturation. 
A number of unanticipated observations were made during analysis of the GUVs 
under the microscope. GUVs seem to be influenced by light in a few ways. Sometimes 
after shining white light or UV light directly onto a vesicle for a short period of time (~30 
s) its shape would change temporarily. A budding vesicle seemed to endocytose the bud 
to form a multilamellar vesicle. A perfectly spherical vesicle could become oblong. 
However, these GUVs seem to be pretty durable and flexible, as after a short recovery 
period (~60 s), the vesicle were stable enough to return to their original shapes. 
The intensity of fluorescence under UV light could sometimes help to discern 
between unilamellar and multilamellar vesicles. Generally, MLVs had a heightened 
intensity under UV light due to the multiple layers of vesicles containing calcein 
disodium salt stacked on top of one another. Typically, white light was primarily used to 
verify the lamellarity of the vesicle, but with this insight it was sometimes possible to 
distinguish if the vesicle was unilamellar or multilamellar using UV light. 
Another major issue was obtaining free-floating GUVs. Many times the GUV 
pellet was composed of vesicles aggregated together. Though sonication and vortexing 
were attempted, these methods seemed too harsh to break up the pellet without destroying 
the integrity of the vesicle membranes. Resuspension by pipetting also did not seem to 
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break up the pellet. As aggregation of the GUVs was a frequently encountered issue, it is 
probably wise to consider an alternative method of liposome formation. 
The gentle hydration method does not yield free-floating giant unilamellar 
vesicles to the level of consistency desired, as only about 14% of the total syntheses 
yielded unilamellar vesicles. This work demonstrated that there is a lack of 
reproducibility seen in the gentle hydration method. Therefore, a more reliable method 
for liposome formation is needed. Generally, this method would still follow the formation 
of a lipid film and subsequent rehydration in aqueous buffer; however, the gentle 
hydration to promote spontaneous swelling over a period of days does not seem to be 
effective. With the technology and resources available to the laboratory group, the focus 
of the project could be shifted toward forming large unilamellar vesicles (LUVs), as these 
smaller entities may be easier to form. Preliminary studies to form LUVs were conducted 
using a method outlined as follows. Phospholipids and cholesterol were mixed by mole % 
in a 20 mL scintillation vial, and evaporated off with a stream of N2 gas. The vial was 
then placed in the desiccator for 30 min to 3 hours to remove residual organic material. 
The lipid film formed was then resuspended in an aqueous buffer containing the calcein 
dye for visualization. Upon adding the buffer, the solution became cloudy. This solution 
was then immediately sonicated at 42 kHz for 15-30 minutes in a sonication bath to 
promote vesicle formation and entrapment of the buffer. The solution was then freeze-
thawed around 10 times to promote dissociation of MLVs. This method was attempted, 
and upon analysis, vesicles formed in the nanometer size range. An example trial of this 























Figure 53: 9:1 PCsoy and cholesterol; modified vesicle procedure; white light and 
fluorescence photographs of vesicles at 200x magnification 
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While this procedure may help to form more unilamellar vesicles rather than MLVs, 
it does not address the problem of obtaining homogenously-sized LUVs. The last step of 
this modified liposome procedure incorporates the principle of extrusion into the 
protocol. A mini-extruder instrument (obtained from Avanti Polar Lipids), allows for the 
passage of vesicle solutions through a membrane with specific pore sizes (Figure 54), 
which causes larger vesicles to be broken up into the size of the membrane pores, and 
smaller vesicles to freely pass through the pores. In this way, vesicle solutions can be 







    Figure 54: Diagram of mini-extruder assembly47 
 
The extruder is composed of two gas-tight syringes that fit into the apparatus 
containing the membrane pore, and allows for a vesicle solution to be passed back and 
forth through the membrane pore many times (5-15) to obtain a homogeneous solution 
(Figure 55). The apparatus also has a heating block, so that the solution can be heated 












Figure 55: Avanti polar lipids mini-extruder instrument 
 
 A solution is deemed more homogeneous when the clarity of the cloudy vesicle 






















       
Figure 56: Vesicle solution before (top) and after (bottom) extrusion 
 
The preliminary trial of the extrusion procedure was analyzed with microscopy; 
however, vesicles were not observed. It is possible that the vesicles were too small to be 
visualized with the compound microscope, as resolution becomes quite poor at high 
magnifications, and the size of the membrane pore used was only 1 μm. The vesicles that 
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formed were most likely in the nanometer size range, which is too small to be seen with 
the microscopes available for use in our laboratories. It is also possible that the 12 passes 
back and forth through the membrane pore were too harsh for the vesicle solution and 
broke up the membranes completely.  
 To address this problem of visualization and affirmation of LUV formation, 
dynamic light scattering (DLS) can be used in the future. DLS is a technique that 
measures the size of particles in solution. It can be used for particles with diameters from 
a few nanometers to about 5 μm. The instrument consists of a laser source, sample cell to 
hold the solution, a photomultiplier detection tube, amplifier, and computer and readout 
system. The results obtained are translation diffusion coefficients (DT) which can then be 
related to particle size.49 If the DLS were used to measure particle size of extruded 
vesicle solutions, it could serve as one way to verify their formation. If they are too small 
to be verified with fluorescence microscopy on the available compound microscope, 
other microscopy/methods would then need to be explored to verify the lamellarity and 
encapsulation efficiency of the vesicles.  
 In order for GUVs to be effective in their projected medical and biochemical 
applications, the stability of these vesicles still needs to be studied. There are several 
factors that affect vesicle stability, including osmolarity, pH, salinity, and temperature. 
The chosen method for forming the GUVs will dictate many of these factors, and so the 
manner of formation is an important contributor to stability as well. Over time when 
vesicles become unstable, they can undergo budding, lysis, or aggregation.16 Researchers 
have reported stability over a period of weeks31, while others report stability in terms of 
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hours or days.16 Ideally, for GUVs used as drug delivery systems, the vesicles would 
need to be able to last anywhere from hours to days to carry out their purpose. If the 
vesicles were to be used in experiments with biochemical assays or techniques, they 
would need to be stable enough to withstand changing physiological conditions such as 
different chemical concentration gradients or electric fields.16 Vesicles loaded with drugs 
would need to be able to retain the drugs for an extended period of time, possibly up to 
months when stored at 4°C. It may be necessary to freeze-dry liposomal formulations in 
order to achieve this length of stability, which has been made possible by incorporating 
sugars such as glucose or sucrose within the internal and external solutions of vesicles. 
The freeze-dried formations can be stored for much longer than the vesicles in swelling 
solution.20 Others have suggested using antioxidants such as alpha-tocopherol or beta-
hydroxytoluene to increase stability of liposomes.20  
 Overall, conditions were optimized for giant unilamellar vesicle formation, and 
more knowledge about the stability of phospholipid membranes was gained. New 
methods will be sought out in the future to continue determining the roles of 

































































































































APPENDIX C: Manual for Fluorescence Microscopy Use 
Nikon Eclipse 80i with X-cite 120 Fluorescence Illumination System Exfo 
 Camera: Nikon Digital Sight DS-U3 and NIS Elements Software programming 
 
A.) Power button: Located on the back left of microscope above power cord 
 
B.) Objective lenses: 4x, 10x, 20x, 40x, higher oil lenses 
 
C.) Magnification dial: Located to the back right of objective lenses; allows you up 
magnification by 1x, 1.25x, 1.5x, or 2x 
 
D.) Focal light size: Dial located on bottom front right section of microscope; allows 
you to change amount of light coming through the bottom light source 
 
E.) Open closed switch: Switch located underneath objective lens stage; allows you to 
open/brighten and close/dim the light source 
 
F.) Filter dial: Located above the objective lenses; allows you to switch between 
filters 1-6, 1 being DAPI, 2 being GFP, 3 being Rhodamine, 4 being FITC, and 5 
and 6 being white light 
 
G.) Iris diaphragm dial: Located above the open closed switch; allows for changing of 
filter when switching between objective lenses, 0 goes with 4x, N1 with 10x, N2 
with 20x 
 
H.) Light source: Located to the front bottom left of the scope, opens and closes the 




I.) Stage dials: Located on middle right of microscope; allows you to move the slide 
around 
 
J.) Focus dials: Located on middle left of microscope; allows you to raise and lower 
stage to obtain a better focus 
 
K.) Photo to Lens Switch: located next to the binocular lenses; allows you to control 
if the light is totally used for the camera, halfway in between camera and lens, or 
totally seen through the lens 
 




General Directions for Fluorescence Use: 
1.) After turning on the fluorescence illumination box, let it warm up for 5 minutes or 
until the light bulb stops blinking 
2.) Wait at least 15 minutes before turning the box off 
3.) To use fluorescence illumination, turn the white light source off and then turn the 
filter switch to open 
4.) Only let UV light shine through for a short amount of time to observe and take a 


























1.) Turn on power button, wait a minute for system to warm up 
2.) Click on the NIS Elements Software icon on the computer desktop 
3.) Adjust exposure manually as needed, smaller exposure will give a darker picture 
and longer exposure will give a lighter picture. 
4.) Adjust the focus on the microscope to get the picture in better focus (Tip: The 
focus point for looking through the binoculars and looking at the picture on the 
computer screen will be different) 
5.) Use the scale option to measure the relative particle size in pixels 
6.) Pixel to micron conversion at 100x magnification is about 1000 pixels to 225 
microns, or 100 px to 22.5 microns. At 200x magnification is about 1000 pixels to 
112.5 microns, or 100 px to 11.25 microns. 
7.) Save photos taken with the date, exposure, magnification, filter type, and other 
needed information 
8.) Use the photo to lens switch to adjust exposure even more by having all the light 
go to the camera to obtain a better photo  
9.) If the picture color seems off, find the edge of the slide and click Auto White to 
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